Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (8)

Search Parameters:
Keywords = sebaceous hyperplasia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
11 pages, 2632 KiB  
Article
Treatment of Sebaceous Hyperplasia by High-Frequency Focused Ultrasound (HIFU): A Comprehensive Exploration with Clinical Insights
by Bartosz Woźniak, Natalia Sauer, Anna Pogorzelska-Antkowiak, Piotr Dzięgiel and Jacek Calik
J. Clin. Med. 2025, 14(4), 1305; https://doi.org/10.3390/jcm14041305 - 16 Feb 2025
Viewed by 2979
Abstract
Background: Sebaceous hyperplasia (SH) is a common benign condition characterized by enlarged sebaceous glands, often requiring treatment for cosmetic or symptomatic reasons. Conventional therapies include laser ablation, electrosurgery, and cryotherapy, but these may be associated with discomfort, scarring, or recurrence. High-Frequency Focused Ultrasound [...] Read more.
Background: Sebaceous hyperplasia (SH) is a common benign condition characterized by enlarged sebaceous glands, often requiring treatment for cosmetic or symptomatic reasons. Conventional therapies include laser ablation, electrosurgery, and cryotherapy, but these may be associated with discomfort, scarring, or recurrence. High-Frequency Focused Ultrasound (HIFU) has emerged as a non-invasive alternative. This study evaluates the efficacy, safety, and patient acceptability of HIFU for the treatment of SH. Methods: Six patients with a total of 33 SH lesions underwent a single HIFU session at a frequency of 20 MHz. Lesion resolution was assessed clinically and dermatoscopically, while secondary outcomes included patient-reported pain levels and treatment-related side effects. Follow-up evaluations were conducted to determine therapeutic response and tolerability. Results: Post-treatment, 87.9% (n = 29) of lesions achieved complete resolution, while 12.1% (n = 4) demonstrated partial reduction in size. Patients reported minimal discomfort during the procedure, describing it as virtually painless. The side effect profile was favorable, with no significant adverse events recorded. Conclusions: HIFU at 20 MHz is an effective and well-tolerated treatment for SH, offering high rates of lesion clearance with minimal discomfort and a low risk of complications. These findings support the role of HIFU as a promising non-invasive alternative to traditional SH treatments, aligning with the trend toward less aggressive dermatological interventions. Further studies with larger cohorts and long-term follow-up are warranted to confirm these results. Full article
(This article belongs to the Special Issue New Treatments for Inflammatory and Neoplastic Skin Diseases)
Show Figures

Figure 1

11 pages, 6714 KiB  
Article
Efficient Topical Treatment of Canine Nodular Sebaceous Hyperplasia with a Nitric Acid and Zinc Complex Solution
by Lina Gustafsson, Alison Wilson and Kerstin Bergvall
Animals 2024, 14(4), 570; https://doi.org/10.3390/ani14040570 - 8 Feb 2024
Viewed by 13786
Abstract
Nodular sebaceous gland hyperplasia in the often middle-aged to old dog is a common, benign proliferation that results in exophytic, pink to yellow, alopecic, and often multilobulated nodules. Removal is usually carried out by surgical excision. As many old dogs have comorbidities that [...] Read more.
Nodular sebaceous gland hyperplasia in the often middle-aged to old dog is a common, benign proliferation that results in exophytic, pink to yellow, alopecic, and often multilobulated nodules. Removal is usually carried out by surgical excision. As many old dogs have comorbidities that increase the risk of anesthesia, a topical treatment is warranted. We hypothesized that the application of a solution containing nitric acid, zinc, copper, and organic acids (Verrutop®), would be a safe and efficient way to treat these nodules. Eleven dogs with a total of 29 nodules, grossly compatible with nodular sebaceous gland hyperplasia, were included in the study. Eighteen of the nodules were treated; 11 were left untreated. No anesthesia or sedation was needed. Four weeks after one application, 17/18 treated nodules had decreased by 100% in volume. There was a statistically significant difference in percentual volume change between the treated and untreated nodules from day 0 to day 28 (p < 0.0001). No serious side effects were noted. Sebaceous hyperplasia cannot always be distinguished grossly from sebaceous tumors. Cytological evaluation can be helpful, and in cases of deviant macroscopic features, local recurrence, or more aggressive behavior, the appropriate intervention would be to biopsy or excise the nodule for histopathology. Topical application of Verrutop® is an easy, low-cost, and efficient way to remove canine sebaceous gland hyperplasia with minimal side effects in cases where surgery and anesthesia are not desired. Full article
Show Figures

Figure 1

19 pages, 4472 KiB  
Article
Healing Process after High-Intensity Focused Ultrasound Treatment of Benign Skin Lesions: Dermoscopic Analysis and Treatment Guidelines
by Jacek Calik, Tomasz Zawada, Torsten Bove, Piotr Dzięgiel, Anna Pogorzelska-Antkowiak, Jacek Mackiewicz, Bartosz Woźniak and Natalia Sauer
J. Clin. Med. 2024, 13(4), 931; https://doi.org/10.3390/jcm13040931 - 6 Feb 2024
Cited by 4 | Viewed by 5236
Abstract
Background: High-Intensity Focused Ultrasound (HIFU) has emerged as a precise and non-invasive modality for tissue ablation and healing. This study presents a detailed dermoscopic analysis of skin healing post-High-Intensity Focused Ultrasound (HIFU) treatment, focusing on common benign skin lesions, such as seborrheic [...] Read more.
Background: High-Intensity Focused Ultrasound (HIFU) has emerged as a precise and non-invasive modality for tissue ablation and healing. This study presents a detailed dermoscopic analysis of skin healing post-High-Intensity Focused Ultrasound (HIFU) treatment, focusing on common benign skin lesions, such as seborrheic keratosis, sebaceous hyperplasia, vascular lesions, and sebaceous nevi. Methods: Prior to HIFU treatment, a comprehensive assessment was conducted, integrating ultrasound scanning and clinical evaluations. The TOOsonix System ONE-M was employed for HIFU treatments, with parameters tailored to each lesion type. Results: A common pattern observed across all lesions includes initial whitening post treatment, followed by scab formation and the development of a pink area with reparative vessels. This study, however, highlights distinct differences in fibrosis patterns and healing timelines across different lesion types. Each lesion type exhibited unique fibrosis patterns post treatment. Flatter variants of seborrheic keratosis healed within a month, displaying hypopigmentation and reparative vessels, alongside a distinct lattice fibrosis pattern in more verrucous forms, which took about two months to heal. Sebaceous hyperplasia, characterized by rapid healing within three weeks, demonstrated fibrosis with pink areas and perpendicular white lines, concluding with a slight depression. Vascular lesions varied in healing time based on depth, with superficial ones showing whitening and crust formation, while deeper lesions had vessel occlusion and size reduction accompanied by concentric fibrotic bands. Sebaceous nevi presented the longest healing duration of three months, characterized by amorphous white-gray structures, scab formation, and the emergence of pink areas with branching vessels, leading to clear skin with reduced white lines. Conclusions: in conclusion, this meticulous clinical evaluation highlights the unique healing characteristics and timelines for each skin lesion type treated with HIFU. These insights are invaluable for optimizing follow-up assessments, identifying potential complications, and refining treatment protocols. By providing detailed insights into the healing timelines and patterns for different types of lesions, patients can be better informed about their post-treatment journey. Full article
(This article belongs to the Section Dermatology)
Show Figures

Figure 1

13 pages, 1595 KiB  
Review
Sebaceous Neoplasms
by Ilias Papadimitriou, Efstratios Vakirlis, Elena Sotiriou, Katerina Bakirtzi, Aimilios Lallas and Demetrios Ioannides
Diagnostics 2023, 13(10), 1676; https://doi.org/10.3390/diagnostics13101676 - 9 May 2023
Cited by 15 | Viewed by 7174
Abstract
Sebaceous neoplasms describe a group of tumors with sebaceous differentiation commonly seen in lesions located primarily in the face and neck. The majority of these lesions are benign, while malignant neoplasms with sebaceous differentiation are uncommon. Sebaceous tumors present a strong association with [...] Read more.
Sebaceous neoplasms describe a group of tumors with sebaceous differentiation commonly seen in lesions located primarily in the face and neck. The majority of these lesions are benign, while malignant neoplasms with sebaceous differentiation are uncommon. Sebaceous tumors present a strong association with the Muir–Torre Syndrome. Patients suspected with this syndrome should undergo neoplasm excision, followed by histopathologic and additional immunohistochemistry and genetics examinations. Clinical and dermoscopic features of the sebaceous neoplasms, as well as management procedures collected from the literature analysis regarding sebaceous carcinoma, sebaceoma/sebaceous adenoma, and sebaceous hyperplasia are described in the current review. A special note is made for describing the Muir–Torre Syndrome in patients presenting multiple sebaceous tumors. Full article
(This article belongs to the Special Issue Skin and Cutaneous Adnexal Tumors: Diagnosis and Management)
Show Figures

Figure 1

7 pages, 3243 KiB  
Article
GLUT1 Expression in Cutaneous Sebaceous Lesions Determined by Immunohistochemical Staining Patterns
by Cynthia Reyes Barron and Bruce R. Smoller
Dermatopathology 2021, 8(3), 258-264; https://doi.org/10.3390/dermatopathology8030031 - 5 Jul 2021
Cited by 2 | Viewed by 3397
Abstract
GLUT1 is a membrane associated carrier protein that functions in the physiologic transport of glucose across cell membranes. Multiple studies have shown an increased GLUT1 expression in various tumor types and a role in cancer prognosis. The aim of this study was to [...] Read more.
GLUT1 is a membrane associated carrier protein that functions in the physiologic transport of glucose across cell membranes. Multiple studies have shown an increased GLUT1 expression in various tumor types and a role in cancer prognosis. The aim of this study was to determine whether cutaneous sebaceous lesions have a differential expression of GLUT1 by immunohistochemistry (IHC). GLUT1 IHC was performed on excision specimens of ten cases of sebaceous carcinoma, nine of sebaceoma, ten of sebaceous adenoma, and ten of sebaceous hyperplasia. Intense, diffuse cytoplasmic staining was observed in sebaceous carcinoma. The pattern of GLUT1 staining in sebaceomas and sebaceous adenomas consisted of a gradient of intense cytoplasmic staining in the basaloid cells with a decreased intensity to membranous staining only and absent staining in mature sebaceous cells. In lesions of sebaceous hyperplasia, GLUT1 staining outlined the basal layer of each gland; cytoplasmic staining was minimal to absent. Increased cytoplasmic staining of GLUT1 may correlate with cellular metabolic and proliferative activity. GLUT1 has potential utility in differentiating sebaceous lesions. Full article
Show Figures

Figure 1

11 pages, 1297 KiB  
Article
Androgen and Estrogen Receptor Expression in Different Types of Perianal Gland Tumors in Male Dogs
by Adam Brodzki, Wojciech Łopuszyński, Yolanda Millan, Marcin R. Tatara, Piotr Brodzki, Katarzyna Kulpa and Natalia Minakow
Animals 2021, 11(3), 875; https://doi.org/10.3390/ani11030875 - 19 Mar 2021
Cited by 4 | Viewed by 4095
Abstract
Perianal gland tumors are modified sebaceous glands present in the skin of the perianal region in the dog. Hormonal stimulation may induce hyperplasia of the perianal glands or their neoplastic progression. The presence of androgen (AR) and estrogen (ER) receptors have been demonstrated [...] Read more.
Perianal gland tumors are modified sebaceous glands present in the skin of the perianal region in the dog. Hormonal stimulation may induce hyperplasia of the perianal glands or their neoplastic progression. The presence of androgen (AR) and estrogen (ER) receptors have been demonstrated both in normal perianal glands as well as in perianal tumors. The aim of the study was an immunohistochemical assessment of the expression of estrogen and androgen receptors in perianal gland tumors in dogs as an applicatory marker for antihormonal treatment. Biopsy samples of perianal masses were collected from 41 male dogs. A histopathological examination revealed 24 adenomas, 12 epitheliomas and five carcinomas. The immunohistochemical staining showed a mainly nuclear expression of AR and ER in the neoplastic cells. Both the androgen and estrogen receptors were expressed in adenoma, epithelioma and carcinoma cases; however, the highest expression of the receptors was stated in the adenoma and epithelioma. In the case of the carcinoma, the expression of sex hormone receptors was very weak. The differences of the number of cells expressing AR and ER as well as the observed differentiated intensity of staining in the studies demonstrated that the determination of the expression of the sex hormone receptors may be useful to elaborate a diagnostic and therapeutic algorithm. Full article
(This article belongs to the Special Issue Spontaneous Neoplasms in Animals)
Show Figures

Figure 1

8 pages, 2231 KiB  
Case Report
Histological and Immunohistochemical Features of Trichoblastoma in a Sarda Breed Sheep
by Marta Polinas, Giovanni P. Burrai, Veronica Vitiello, Laura Falchi, Maria T. Zedda, Gerolamo Masala, Vincenzo Marras, Giulia Satta, Alberto Alberti and Elisabetta Antuofermo
Animals 2020, 10(11), 2039; https://doi.org/10.3390/ani10112039 - 4 Nov 2020
Cited by 3 | Viewed by 4589
Abstract
Skin tumors with adnexal differentiation are commonly reported in dogs and cats, while only anecdotal evidence is available in sheep. Here we illustrate the macroscopic, histologic, and immunohistochemical features of a cutaneous lesion with adnexal differentiation in a 6-year-old female Sarda breed sheep, [...] Read more.
Skin tumors with adnexal differentiation are commonly reported in dogs and cats, while only anecdotal evidence is available in sheep. Here we illustrate the macroscopic, histologic, and immunohistochemical features of a cutaneous lesion with adnexal differentiation in a 6-year-old female Sarda breed sheep, surgically treated for a horn-like mass located in the left pinna. Additionally, we investigate a possible contribution of Ovine Papillomaviruses (OaPVs). Histologically, the dermis was expanded by an expansive and unencapsulated multilobulated nodule composed of cuboidal to spindle basaloid cells arranged in variably-sized cytokeratins (CK) AE1-AE3, CK 5/6 and CK 34 beta E12, p63—positive winding cords with a characteristic palisade arrangement of neoplastic cells in the periphery of the tumor. Based on these results, the cutaneous neoplasm was diagnosed as a trabecular trichoblastoma with spindle cells and rare structures resembling papillary mesenchymal bodies. Additionally, multiple enlarged sebaceous lobules clustered around dilated ducts suggestive of sebaceous gland hyperplasia were detected near the trichoblastoma. No PV DNA was found in the examined tissues, suggesting that ovine PVs are not involved in the pathogenesis of the present skin tumors with adnexal differentiation. Further investigations and efforts are required to elucidate the prevalence of skin tumors with adnexal differentiation in this species. Full article
(This article belongs to the Special Issue Spontaneous Neoplasms in Animals)
Show Figures

Figure 1

5 pages, 773 KiB  
Case Report
Clear Cell Myoepithelioma of Palate with Emphasis on Clinical and Histological Differential Diagnosis
by Bindu J. Nair, Velayudhannair Vivek, Trivandrum T. Sivakumar, Anna P. Joseph, Babyamma Raghavanpillai Varun and Vinod Mony
Clin. Pract. 2014, 4(1), 628; https://doi.org/10.4081/cp.2014.628 - 7 May 2014
Cited by 4 | Viewed by 915
Abstract
Myoepitheliomas account for less than 1% of all salivary gland tumors and mostly occur in the parotid gland and palate. A 58-year old male patient reported to the Outpatient Department of PMS College of Dental Science and Research (Kerala, India) with a slow [...] Read more.
Myoepitheliomas account for less than 1% of all salivary gland tumors and mostly occur in the parotid gland and palate. A 58-year old male patient reported to the Outpatient Department of PMS College of Dental Science and Research (Kerala, India) with a slow growing painless swelling on the palate for 4 years. Pleomorphic adenoma, basal cell adenoma, myoepithelioma, cyst adenoma, lipoma, neurofibroma, neurilemmoma and leiomyoma were considered. Histopathology revealed a thinly encapsulated tumor composed mainly of sheets of clear cells mixed with cells having eosinophilic cytoplasm. Histopathological differential diagnosis included pleomorphic adenoma, oncocytoma, oncocytic hyperplasia, sebaceous adenoma, malignant salivary gland neoplasms and metastatic lesions from kidney and thyroid. Myoepitheliomas mostly occur in the parotid gland and palatal region and various histological types of myoepithelioma are described. Myoepitheliomas of the palate are rare with clear cell variant even rarer. Full article
Back to TopTop